Top Markets
Coin of the day
Radiopharm Theranostics Limited Radiopharm Theranostics Limited

Radiopharm Theranostics Limited

RAD
Classement en actions #29689
Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company,... Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs. The company develops several products, including RAD101, a pivalate brain metastasis diagnostic; RAD102, a pivalate therapeutic; RAD201a, a Nano-mAb HER-2 breast diagnostic; RAD202, a Nano-mAb HER-2 breast therapeutic; RAD203, a Nano-mAb PDL1 non-small cell lung diagnostic; and RAD204, a Nano-mAb PDL1 non-small cell lung therapeutic. Additionally, it is developing RAD301 and RAD302, which are Avß6-Integrin pancreatic diagnostic and therapeutic products; RAD401, a PSA-mAb prostate cancer diagnostic; RAD402, a PSA-mAb prostate cancer therapeutic; RAD601, a PTPµ glioblastoma diagnostic; and RAD602, a PTPµ glioblastoma therapeutic. The company has a strategic agreement with Lantheus Holdings, Inc. to advance the clinical development of radiopharmaceuticals. The company was incorporated in 2021 and is based in Carlton, Australia.
Prix de l'action
$0.00846342
Capitalisation boursière
$20.02M
Changement (1 jour)
0.00%
Changement (1 an)
-47.56%
Pays
AU
Échange Radiopharm Theranostics Limited (RAD)

Catégorie

Historique du prix de l'action pour Radiopharm Theranostics Limited (RAD)
Prix de clôture le plus élevé : $0.01 le 2026-08-01

Prix de clôture le plus bas : $0.24 le 2021-11-01
Historique du prix de l'action de Radiopharm Theranostics Limited de 2021 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) -22.80%
2025 -10.60%
2024 -63.52%
2023 -27.28%
2022 -71.97%
2021 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$527.89 35.09%
US
$996.61 51.72%
NL
$117.42 -19.34%
AU
$730.65 5.32%
CH
$1.07K -5.58%
KR